Nomura Asset Management Co. Ltd. lifted its stake in Xylem Inc. (NYSE:XYL – Free Report) by 3.4% during the fourth quarter, HoldingsChannel reports. The fund owned 274,506 shares of the industrial products company’s stock after purchasing an additional 9,102 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Xylem were worth $37,382,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of XYL. AQR Capital Management LLC increased its stake in shares of Xylem by 14.4% in the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after acquiring an additional 3,900 shares during the last quarter. NewEdge Advisors LLC increased its stake in shares of Xylem by 3.3% in the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after acquiring an additional 132 shares during the last quarter. Empowered Funds LLC increased its stake in shares of Xylem by 56.1% in the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after acquiring an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Xylem by 97.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock worth $1,442,000 after acquiring an additional 5,509 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after acquiring an additional 635 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Xylem Stock Down 1.1%
XYL stock opened at $108.38 on Tuesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a 50-day moving average of $117.60 and a two-hundred day moving average of $129.31. The stock has a market capitalization of $25.76 billion, a price-to-earnings ratio of 26.96, a price-to-earnings-growth ratio of 1.56 and a beta of 1.05.
Xylem announced that its board has authorized a stock buyback plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to reacquire up to 4.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
Xylem Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Thursday, May 28th. Xylem’s dividend payout ratio is 42.79%.
Insider Transactions at Xylem
In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jerome A. Peribere bought 1,210 shares of Xylem stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $116.61 per share, with a total value of $141,098.10. Following the purchase, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their position. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Several research firms have commented on XYL. Oppenheimer lowered their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Citigroup lowered their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Barclays lowered their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 29th. Mizuho set a $138.00 target price on shares of Xylem in a research report on Wednesday, February 11th. Finally, Stifel Nicolaus lowered their target price on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $152.77.
View Our Latest Stock Analysis on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Further Reading
- Five stocks we like better than Xylem
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
